Related Experiment Video
Updated: Aug 22, 2026

Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats
Published on: November 20, 2015
Prematurity and intrauterine growth retardation--double jeopardy?
Rivka H Regev1, Brian Reichman
1Neonatal Unit and Neonatal Follow-Up Clinic, Neonatal Department, Meir Hospital, Sapir Medical Center, Kfar Saba 44281, Israel. regevdr@netvision.net.il
Insights
Infants born small for gestational age (SGA) with intrauterine growth restriction (IUGR) face higher risks of death and serious health issues. IUGR may also program later-life diseases like cardiovascular conditions and diabetes.
Area of Science:
- Neonatalogy
- Perinatology
- Developmental Pediatrics
Background:
- Intrauterine growth restriction (IUGR) significantly increases mortality and major neonatal morbidities in premature infants.
- These complications, including respiratory distress syndrome (RDS), bronchopulmonary dysplasia (BPD), retinopathy of prematurity (ROP), and necrotizing enterocolitis (NEC), are exacerbated by suboptimal fetal growth.
- Emerging evidence links IUGR to the later development of adult-onset cardiovascular diseases, hypertension, and diabetes mellitus.
Purpose of the Study:
- To discuss the pathophysiologic processes underlying IUGR and its consequences.
- To highlight the role of IUGR as a risk factor for long-term health problems.
- To emphasize the need for experimental research into IUGR's etiology and pathophysiology.
Main Methods:
- Review of pathophysiologic processes initiated in utero and continuing postnatally.
- Analysis of recently reported data on IUGR and long-term health outcomes.
- Discussion of experimental research directions.
Main Results:
- Premature infants with IUGR exhibit a substantially increased risk of mortality and severe neonatal morbidities.
- Suboptimal fetal growth intensifies the severity of prematurity-related complications.
- IUGR is identified as a programming risk factor for adult cardiovascular diseases, hypertension, and diabetes.
Conclusions:
- Understanding the pathophysiology of IUGR is crucial for addressing neonatal complications.
- Interventions targeting IUGR may reduce both short-term and long-term mortality and morbidity in small for gestational age (SGA) infants.
- Further experimental research is essential to develop effective strategies for mitigating the risks associated with IUGR.
Abstract:
Premature infants born with IUGR are at a several-fold increased risk for mortality and major neonatal morbidities, including RDS, BPD, ROP, and NEC. These severe complications of prematurity are intensified by the effect of suboptimal fetal growth. The possible pathophysiologic processes initiated in utero and continuing after birth have been discussed. Recently reported data suggest that IUGR is a risk factor in programming for the later development of cardiovascular diseases, hypertension, and diabetes mellitus in adult life. Experimental research related to the pathophysiology and etiology of these conditions may enable appropriate intervention directed at reducing the excess risk associated with the short- and long-term mortality and morbidity among premature SGA infants.
Related Concept Videos
Teratogenicity
Diabetes Mellitus: Type 2 and Gestational
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Regression Toward the Mean
Genomic Imprinting and Inheritance
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
Nature and Nurture

